- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02075866
Finnish Genetic Study for Arrhythmic Events (FinGesture)
March 3, 2014 updated by: University of Oulu
Finnish Genetic Study for Arrhythmic Events (FinGesture is a prospective case-control study assessing the characteristics and genetic background of consecutive series of autopsy verified out-of-hospital victims of SCD vs. survivors of an acute coronary event in a specific geographical area in northern Finland.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
8000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oulu, Finland, 90014
- Recruiting
- Oulu University Hospital
-
Contact:
- Eeva Hookana, PhD
- Phone Number: 35883154464
- Email: eeva.hookana@oulu.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive victims of sudden cardiac death verified by medicolegal autopsy (cases).
Acute coronary event patients admitted to the Oulu University Hospital who survived to be discharged from the hospital (controls).
Description
Inclusion Criteria:
- Sudden cardiac death verified by medicolegal autopsy (cases)
- Acute coronary event (increased troponin levels/ECG markers of ischemia/angina pectoris; two out of three criteria) (controls).
Exclusion Criteria:
- Sudden death due to other causes (cases).
- Acute coronary event patients who died during hospitalization (controls).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
sudden cardiac death
Time Frame: 20 years
|
20 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1998
Primary Completion (Anticipated)
December 1, 2017
Study Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
February 27, 2014
First Submitted That Met QC Criteria
February 27, 2014
First Posted (Estimate)
March 3, 2014
Study Record Updates
Last Update Posted (Estimate)
March 4, 2014
Last Update Submitted That Met QC Criteria
March 3, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Uoulu-FinGesture
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sudden Cardiac Death
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
University Hospital Southampton NHS Foundation...WithdrawnCardiac Arrest | Sudden Death, Cardiac
-
Solae, LLCProvident Clinical ResearchCompletedCardiovascular Disease | Sudden Cardiac Death | Sudden Cardiac Arrest
-
Zoll Medical CorporationTerminatedSudden Cardiac Death | Sudden Cardiac ArrestUnited States
-
Solae, LLCProvident Clinical ResearchCompletedCardiovascular Disease | Sudden Cardiac Death | Sudden Cardiac ArrestUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceRecruitingHeart Failure | Implantable Cardioverter Defibrillator | Primary Prevention of Sudden Cardiac DeathFrance
-
Zoll Medical CorporationCompletedHeart Failure | Sudden Cardiac Death | Sudden Cardiac Arrest | Heart Failure Low OutputFrance, United States, Germany, Austria
-
University of LuebeckProf. Jürgen Kuschyk, M.D; Giovanni Forleo, M.D.; Mauro Biffi, M.D.RecruitingSudden Cardiac DeathGermany
-
Deutsches Herzzentrum MuenchenCompletedSudden Cardiac DeathGermany
-
Jingfeng WangFudan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University... and other collaboratorsEnrolling by invitation